| scholarly article | Q13442814 |
| P50 | author | Kenji Maeda | Q55153732 |
| P2093 | author name string | Hiroaki Mitsuya | |
| Arun K Ghosh | |||
| Yasuhiro Hayashi | |||
| Debananda Das | |||
| Darshan V Desai | |||
| Simon B Chang | |||
| Navnath Gavande | |||
| P2860 | cites work | Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists | Q24619974 |
| Molecular Shape and Medicinal Chemistry: A Perspective | Q27659860 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene | Q29615351 | ||
| Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes | Q29616736 | ||
| Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database | Q30494222 | ||
| Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor | Q30832371 | ||
| Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor | Q31821860 | ||
| Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha | Q33797534 | ||
| Isolation of a new human retrovirus from West African patients with AIDS. | Q34038984 | ||
| Structural and molecular interactions of CCR5 inhibitors with CCR5. | Q34494226 | ||
| Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants | Q34737640 | ||
| Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects | Q35879000 | ||
| GluVII:06--a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors | Q36570350 | ||
| Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs | Q36703042 | ||
| Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition. | Q37071732 | ||
| Lifting the lid on GPCRs: the role of extracellular loops | Q37921853 | ||
| Development of novel CXCR4-based therapeutics | Q37979306 | ||
| CCR5 inhibitors: emergence, success, and challenges | Q38005459 | ||
| Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). | Q38339478 | ||
| Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication | Q38921090 | ||
| Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist | Q39104422 | ||
| Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5. | Q39202247 | ||
| Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1. | Q39276845 | ||
| Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication | Q39469626 | ||
| A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140. | Q39507599 | ||
| Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo | Q39521135 | ||
| Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site | Q39821124 | ||
| Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation. | Q40188327 | ||
| AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. | Q41071776 | ||
| Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses | Q41104028 | ||
| Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities | Q45742231 | ||
| The different ways through which specificity works in orthosteric and allosteric drugs | Q47577552 | ||
| Comparison of Shape-Matching and Docking as Virtual Screening Tools | Q56853909 | ||
| Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
| Azamacrocyclic metal complexes as CXCR4 antagonists | Q83396529 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1895-1904 | |
| P577 | publication date | 2015-01-12 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors | |
| P478 | volume | 59 |
| Q64082901 | Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s |
| Q56700832 | Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery |
| Q45325496 | Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency |
| Q36212626 | Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library |
| Q27468774 | Membrane-associated GRP78 helps subgroup J avian leucosis virus enter cells |
| Q50870345 | Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study. |
| Q34550666 | Structural Analysis of Chemokine Receptor-Ligand Interactions |
| Q39766459 | Symmetrical bis-tertiary amines as novel CXCR4 inhibitors |
Search more.